---
title: "Definitive Healthcare | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 55.2 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295447065.md"
datetime: "2026-08-10T20:32:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295447065.md)
  - [en](https://longbridge.com/en/news/295447065.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295447065.md)
generator: "portal-rs"
---

# Definitive Healthcare | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 55.2 M

Revenue: As of FY2026 Q2, the actual value is USD 55.2 M, missing the estimate of USD 55.39 M.

EPS: As of FY2026 Q2, the actual value is USD -0.05, beating the estimate of USD -0.0785.

EBIT: As of FY2026 Q2, the actual value is USD -6.422 M.

### Second Quarter 2026 Financial Highlights

#### Revenue

Definitive Healthcare Corp. reported revenue of $55.2 million for the second quarter of 2026, marking a 9% decrease from $60.8 million in Q2 2025. 

#### Net Loss

Net loss for Q2 2026 was - $7.5 million, or -14% of revenue, compared to - $9.3 million, or -15% of revenue, in Q2 2025. 

#### Adjusted Net Income

Adjusted Net Income for Q2 2026 was $7.5 million, down from $9.7 million in Q2 2025. 

#### Adjusted EBITDA

Adjusted EBITDA reached $14.6 million in Q2 2026, representing 26% of revenue, a decrease from $18.7 million, or 31% of revenue, in Q2 2025. 

#### Cash Flow

Cash Flow from Operations was $11.5 million in the second quarter of 2026. Unlevered Free Cash Flow for the quarter stood at $11.6 million. 

#### Gross Profit and Margin

GAAP gross profit was $40,541 thousand in Q2 2026, compared to $46,613 thousand in Q2 2025. The GAAP gross margin was 73% in Q2 2026, down from 77% in Q2 2025. Adjusted gross profit was $44,160 thousand (80% margin) in Q2 2026, compared to $49,981 thousand (82% margin) in Q2 2025. 

#### Operating Expenses

Total operating expenses were $47,289 thousand in Q2 2026, a decrease from $50,783 thousand in Q2 2025. Sales and marketing expenses were $19,158 thousand in Q2 2026, compared to $20,469 thousand in Q2 2025. Product development expenses were $6,756 thousand in Q2 2026, compared to $7,968 thousand in Q2 2025. General and administrative expenses were $10,806 thousand in Q2 2026, compared to $12,673 thousand in Q2 2025. Depreciation and amortization expenses were $8,542 thousand in Q2 2026, compared to $9,001 thousand in Q2 2025. Transaction, integration, and restructuring expenses increased to $2,027 thousand in Q2 2026 from $672 thousand in Q2 2025. 

#### Loss from Operations

Definitive Healthcare Corp. reported a loss from operations of - $6,748 thousand in Q2 2026, compared to - $4,170 thousand in Q2 2025. 

#### Other Income/Expense and Interest

Net interest expense was - $1,375 thousand in Q2 2026, compared to - $1,241 thousand in Q2 2025. Other income, net, was $326 thousand in Q2 2026, a significant improvement from other expense, net, of - $3,398 thousand in Q2 2025. 

#### Adjusted Operating Income

Adjusted Operating Income was $11,840 thousand for Q2 2026, down from $15,639 thousand in Q2 2025. 

#### Investing and Financing Activities

Purchases of property, equipment, and data assets were - $2,942 thousand in Q2 2026, compared to - $2,293 thousand in Q2 2025. Repayments of the term loan were - $2,187 thousand in Q2 2026, similar to - $2,188 thousand in Q2 2025. 

### Business Outlook

For Q3 2026, Definitive Healthcare Corp. anticipates revenue between $54.0 million and $55.0 million, with Adjusted Operating Income projected from $10.5 million to $11.5 million, and Adjusted EBITDA from $13.5 million to $14.5 million. For the full year 2026, the company expects revenue between $220.0 million and $222.0 million, Adjusted Operating Income between $45.5 million and $47.5 million, and Adjusted EBITDA between $57.0 million and $59.0 million. Full-year Adjusted Net Income is projected to be between $27.0 million and $29.0 million, with Adjusted Net Income Per Diluted Share between $0.18 and $0.20.

### Related Stocks

- [DH.US](https://longbridge.com/en/quote/DH.US.md)

## Related News & Research

- [Igua Sergipe board signs off Q2 2026 financial results](https://longbridge.com/en/news/297932404.md)
- [Marisa updates financial events calendar for 2026](https://longbridge.com/en/news/297913424.md)
- [Quanta Services announces dividend of R$ 0.03 per unit for Q3 2026](https://longbridge.com/en/news/297931955.md)
- [PulteGroup declares Q3 2026 dividend of R$ 0.9 per unit](https://longbridge.com/en/news/297931957.md)
- [LyondellBasell announces dividend of R$ 1.72 per unit for 3Q 2026](https://longbridge.com/en/news/297814383.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**